BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse

被引:3
作者
Chen, Dan [1 ]
Zhao, Hui-min [1 ]
Deng, Xian-hui [1 ]
Li, Sheng-peng [1 ]
Zhou, Mei-hui [1 ]
Wu, Ya-xian [1 ]
Tong, Ying [1 ]
Yu, Ren-qiang [2 ,3 ]
Pang, Qing-feng [1 ,4 ]
机构
[1] Jiangnan Univ, Wuxi Sch Med, Dept Physiopathol, Wuxi, Peoples R China
[2] Jiangnan Univ, Affiliated Womens Hosp, Wuxi Matern & Child Hlth Care Hosp, Dept Neonatol, Wuxi, Peoples R China
[3] Jiangnan Univ, Affiliated Womens Hosp, Wuxi Matern & Child Hlth Care Hosp, Dept Neonatol, 48 Huaishu Lane, Wuxi, Peoples R China
[4] Jiangnan Univ, Wuxi Sch Med, Dept Physiopathol, 1800 Lihu Ave, Wuxi, Peoples R China
基金
中国国家自然科学基金;
关键词
BCL6; bronchopulmonary dysplasia; inflammation; hyperoxia; NLRP3; BRONCHOPULMONARY DYSPLASIA; CELL; EXPRESSION; IMPROVES; ANGIOGENESIS; PATHOGENESIS; VASCULATURE; APOPTOSIS; EXPOSURE; FIBROSIS;
D O I
10.1080/01902148.2024.2320665
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The transcriptional repressor B-cell lymphoma 6 (BCL6) has been reported to inhibit inflammation. So far, experimental evidence for the role of BCL6 in bronchopulmonary dysplasia (BPD) is lacking. Our study investigated the roles of BCL6 in the progression of BPD and its downstream mechanisms. Methods: Hyperoxia or lipopolysaccharide (LPS) was used to mimic the BPD mouse model. To investigate the effects of BCL6 on BPD, recombination adeno-associated virus serotype 9 expressing BCL6 (rAAV9-BCL6) and BCL6 inhibitor FX1 were administered in mice. The pulmonary pathological changes, inflammatory chemokines and NLRP3-related protein were observed. Meanwhile, BCL6 overexpression plasmid was used in human pulmonary microvascular endothelial cells (HPMECs). Cell proliferation, apoptosis, and NLRP3-related protein were detected. Results: Either hyperoxia or LPS suppressed pulmonary BCL6 mRNA expression. rAAV9-BCL6 administration significantly inhibited hyperoxia-induced NLRP3 upregulation and inflammation, attenuated alveolar simplification and dysregulated angiogenesis in BPD mice, which were characterized by decreased mean linear intercept, increased radical alveolar count and alveoli numbers, and the upregulated CD31 expression. Meanwhile, BCL6 overexpression promoted proliferation and angiogenesis, inhibited apoptosis and inflammation in hyperoxia-stimulated HPMECs. Moreover, administration of BCL6 inhibitor FX1 arrested growth and development. FX1-treated BPD mice exhibited exacerbation of alveolar pathological changes and pulmonary vessel permeability, with upregulated mRNA levels of pro-inflammatory cytokines and pro-fibrogenic factors. Furthermore, both rAAV9-BCL6 and FX1 administration exerted a long-lasting effect on hyperoxia-induced lung injury (>= 4 wk). Conclusions: BCL6 inhibits NLRP3-mediated inflammation, attenuates alveolar simplification and dysregulated pulmonary vessel development in hyperoxia-induced BPD mice. Hence, BCL6 may be a target in treating BPD and neonatal diseases.
引用
收藏
页码:25 / 41
页数:17
相关论文
共 50 条
[41]   Osteopontin protects against hyperoxia-induced lung injury by inhibiting nitric oxide synthases [J].
Zhang Xiang-feng ;
Liu Shuang ;
Zhou Yu-jie ;
Zhu Guang-fa ;
Foda, Hussein D. .
CHINESE MEDICAL JOURNAL, 2010, 123 (07) :929-935
[42]   Connective Tissue Growth Factor Antibody Therapy Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats [J].
Alapati, Deepthi ;
Rong, Min ;
Chen, Shaoyi ;
Hehre, Dorothy ;
Rodriguez, Maria M. ;
Lipson, Kenneth E. ;
Wu, Shu .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 45 (06) :1169-1177
[43]   Antenatal betamethasone attenuates intrauterine infection-aggravated hyperoxia-induced lung injury in neonatal rats [J].
Yoo, Hye Soo ;
Chang, Yun Sil ;
Kim, Jin Kyu ;
Ahn, So Yoon ;
Kim, Eun Sun ;
Sung, Dong Kyung ;
Jeon, Ga Won ;
Hwang, Jong Hee ;
Shim, Jae Won ;
Park, Won Soon .
PEDIATRIC RESEARCH, 2013, 73 (06) :726-733
[44]   Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice [J].
Li, Huai-Dong ;
Zhang, Zhao-Rui ;
Zhang, Qing-Xiang ;
Qin, Zhi-Chu ;
He, Deng-Ming ;
Chen, Jin-Song .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2013, 113 (06) :1555-1563
[45]   Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation [J].
Alsaadi, Mohammad ;
Tezcan, Gulcin ;
Garanina, Ekaterina E. ;
Hamza, Shaimaa ;
McIntyre, Alan ;
Rizvanov, Albert A. ;
Khaiboullina, Svetlana F. .
PHARMACEUTICALS, 2021, 14 (09)
[46]   Granulocyte Colony Stimulating Factor Attenuates Hyperoxia-Induced Lung Injury by Down-Modulating Inflammatory Responses in Neonatal Rats [J].
Jeon, Ga Won ;
Sung, Dong Kyung ;
Jung, Yu Jin ;
Koo, Soo Hyun ;
Choi, Seo Heui ;
Chang, Yun Sil ;
Sin, Jong Beom ;
Park, Won Soon .
YONSEI MEDICAL JOURNAL, 2011, 52 (01) :65-73
[47]   Loss of interleukin-6 enhances the inflammatory response associated with hyperoxia-induced lung injury in neonatal mice [J].
Li, Hengtao ;
Wang, Genzai ;
Lin, Shuzhu ;
Wang, Chunyan ;
Zha, Jianzhong .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) :3101-3107
[48]   Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway [J].
Chen, Shangqin ;
Wu, Qiuping ;
Zhong, Dingjuan ;
Li, Changchong ;
Du, Lizhong .
RESPIRATORY RESEARCH, 2020, 21 (01)
[49]   Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats [J].
Wagenaar, Gerry T. M. ;
Sengers, Rozemarijn M. A. ;
Laghmani, El Houari ;
Chen, Xueyu ;
Lindeboom, Melissa P. H. A. ;
Roks, Anton J. M. ;
Folkerts, Gert ;
Walther, Frans J. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 307 (03) :L261-L272
[50]   Astragaloside IV attenuates lipopolysaccharide induced liver injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation [J].
Sun, Yuxia ;
Ma, Yuhui ;
Sun, Fangyuan ;
Feng, Wentao ;
Ye, Hui ;
Tian, Tianning ;
Lei, Ming .
HELIYON, 2023, 9 (04)